Results 71 to 80 of about 80,641 (196)
Sustained Remission in a Case of Lupus Nephritis with Cyclosporin Therapy
Systemic lupus erythematosus (SLE) in severe form still presents a major therapeutic challenge. Aggressive treatment of severe renal lesions has improved the prognosis of renal disease over the last decade.
Rabbani Malik, Shah Syed, Ahmad Aasim
doaj
Melanoma cells remain resistant to chemotherapy with cisplatin (CisPt) and doxorubicin (DOX). The abnormal expression of Receptor-Interacting Protein Kinase 4 (RIPK4) in certain melanomas contributes to tumour growth through the NFκB and Wnt/β-catenin ...
Bartlomiej Olajossy +5 more
doaj +1 more source
Changes in life-style after liver transplantation [PDF]
Sixty-five pediatric patients who received liver transplants between May 1981 and May 1984 were observed for as many as 5 years and examined for changes in life-style.
Belle, SH +8 more
core
The efficacy of cyclosporin-A, a potent immunosuppressive agent, has not been clearly proven in the management of childhood nephrotic syndrome. The occurrence of early relapse as the dose of cyclosporin is tapered or as soon as the drug is stopped
G G Yilmaz, A G Güven
doaj
Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
Sun Huaibin +3 more
doaj +1 more source
Late follow-up after thoracic duct drainage in cadaveric renal transplantation [PDF]
Thoracic duct drainage was added to conventional immunosuppression with azathioprine, prednisone and, sometimes, antilymphocyte globulin in 83 patients given cadaveric kidneys, including 65 primary graft recipients.
Iwatsuki, S +4 more
core
Randomised trialomania? The multicentre liver transplant trials of tacrolimus [PDF]
Donner, A +7 more
core +1 more source
Orthotopic liver transplantation in children. Two-year experience with 47 patients [PDF]
During a 24-month period (May 1981 to May 1983), 47 pediatric patients (ranging in age from 7 months to 18 years) underwent orthotopic liver transplantation using cyclosporine and prednisone.
Gartner, JC +5 more
core
A Study of arbutin protective effect on cyclosporin A-induced oxidative damage
Background: Cyclosporine A (CsA) is a potent immunosuppressant drug with therapeutic and toxic actions. The use of CsA is limited by its toxicity. Several researchers had proposed that oxidative stress could play an important role in CsA-induced toxicity.
Fatemeh Khadir +5 more
doaj
Study on Cyclosporin A in intervening the progress of IgA nephropathy
Objective To study the effect of cyclosporin A in intervening the progress of IgA nephropathy.Methods 154 selected patients with progressive IgA nephropathy treated in the hospital from April 2012 to March 2016 were randomly divided into control group in
LU Fa-ju, CHEN Yong-jian, YANG Lei
doaj

